We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Caleres
CAL
$475M
| $966K | 0.01% |
49,961
+25,382
| +103% | +$550K |
|
|
AXNX
2052
DELISTED
Axonics, Inc. Common Stock
AXNX
| $965K | 0.01% |
15,415
+8,026
| +109% | +$433K |
|
|
NAPA
2053
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $963K | 0.01% |
52,940
+32,022
| +153% | +$625K |
|
|
TCN
2054
DELISTED
Tricon Residential Inc.
TCN
| $963K | 0.01% |
60,562
+18,677
| +45% | +$285K |
|
2055
Empire State Realty Trust
ESRT
$802M
| $962K | 0.01% |
97,917
-280,946
| -74% | -$2.64M |
|
|
CUK
2056
DELISTED
Carnival PLC
CUK
| $961K | 0.01% |
52,607
+42,331
| +412% | +$790K |
|
2057
Materion
MTRN
$5.85B
| $961K | 0.01% |
11,203
-12,192
| -52% | -$1.04M |
|
2058
Regions Financial
RF
$26.9B
| $960K | 0.01% |
43,126
-540,520
| -93% | -$12.7M |
|
2059
Orion
OEC
$377M
| $957K | 0.01% |
59,925
-25,763
| -30% | -$444K |
|
|
KIII
2060
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
| $957K | 0.01% |
97,748
+30,841
| +46% | +$300K |
|
2061
Zimmer Biomet
ZBH
$18.5B
| $954K | 0.01% |
7,458
-119,295
| -94% | -$14.4M |
|
2062
Guidewire Software
GWRE
$14.7B
| $951K | 0.01% |
10,054
-22,874
| -69% | -$2.19M |
|
2063
Preferred Bank
PFBC
$1.26B
| $950K | 0.01% |
12,817
+1,639
| +15% | +$127K |
|
2064
Pearson
PSO
$9.72B
| $950K | 0.01% |
95,335
-5,894
| -6% | -$53.2K |
|
2065
Standex International
SXI
$3.97B
| $949K | 0.01% |
9,496
-3,931
| -29% | -$412K |
|
2066
C4 Therapeutics
CCCC
$428M
| $947K | 0.01% |
39,024
+5,027
| +15% | +$122K |
|
2067
MasTec
MTZ
$21.9B
| $946K | 0.01% |
10,861
-33,155
| -75% | -$2.9M |
|
2068
SmartRent
SMRT
$270M
| $945K | 0.01% |
186,845
+66,154
| +55% | +$477K |
|
|
VBTX
2069
DELISTED
Veritex Holdings
VBTX
| $945K | 0.01% |
24,770
-17,244
| -41% | -$693K |
|
|
SRCL
2070
DELISTED
Stericycle Inc
SRCL
| $945K | 0.01% |
+16,042
| New | +$929K |
|
2071
Stoke Therapeutics
STOK
$2.13B
| $944K | 0.01% |
44,844
+33,131
| +283% | +$663K |
|
|
LTCH
2072
DELISTED
Latch, Inc. Common Stock
LTCH
| $943K | 0.01% |
220,945
+126,843
| +135% | +$663K |
|
|
SAND
2073
DELISTED
Sandstorm Gold
SAND
| $942K | 0.01% |
116,582
-121,107
| -51% | -$835K |
|
2074
Donnelley Financial Solutions
DFIN
$1.16B
| $941K | 0.01% |
28,287
-29,008
| -51% | -$1.03M |
|
|
SMLR
2075
DELISTED
Semler Scientific
SMLR
| $941K | 0.01% |
+18,996
| New | +$1.27M |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.